Geron Corp. (NASDAQ: GERN) kicked off on Friday, remained unchanged from the previous trading day, before settling in for the closing price of $4.33. Over the past 52 weeks, GERN has traded in a range of $1.64-$5.34.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 46.26% over the last five years. While this was happening, its average annual earnings per share was recorded -6.64%. With a float of $552.62 million, this company’s outstanding shares have now reached $602.80 million.
The firm has a total of 141 workers. Let’s measure their productivity. In terms of profitability, gross margin is -2113.26%, operating margin of -16559.94%, and the pretax margin is -15990.68%.
Geron Corp. (GERN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Geron Corp. is 8.32%, while institutional ownership is 69.62%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp. (GERN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -6.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp. (NASDAQ: GERN) Trading Performance Indicators
Take a look at Geron Corp.’s (GERN) current performance indicators. Last quarter, stock had a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1905.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of Geron Corp. (GERN)
Analysing the last 5-days average volume posted by the [Geron Corp., GERN], we can find that recorded value of 6.36 million was lower than the volume posted last year of 10.59 million. As of the previous 9 days, the stock’s Stochastic %D was 33.09%. Additionally, its Average True Range was 0.20.
During the past 100 days, Geron Corp.’s (GERN) raw stochastic average was set at 52.13%, which indicates a significant increase from 37.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.31% in the past 14 days, which was lower than the 57.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.48, while its 200-day Moving Average is $3.59. Now, the first resistance to watch is $4.38. This is followed by the second major resistance level at $4.44. The third major resistance level sits at $4.54. If the price goes on to break the first support level at $4.23, it is likely to go to the next support level at $4.13. Should the price break the second support level, the third support level stands at $4.07.
Geron Corp. (NASDAQ: GERN) Key Stats
The company with the Market Capitalisation of 2.61 billion has total of 593,133K Shares Outstanding. Its annual sales at the moment are 240 K in contrast with the sum of -184,130 K annual income. Company’s last quarter sales were recorded 880 K and last quarter income was -67,380 K.
